Obesity

Audience: Patients and providers
Status: Clinical guide · patient + provider
Last updated: 2026-03-09

1. Clinical overview

Obesity is a chronic relapsing adiposity-based disease that should be managed through complications, metabolic risk, function, and treatment response rather than body weight alone.

2. Common causes and risk factors

Chronic relapsing disease involving neuroendocrine, metabolic, behavioral, and environmental factors.
Weight bias and access barriers can worsen outcomes and adherence.

3. Typical symptoms

No single symptom profile; assess complications (T2D, OSA, NAFLD, HTN, OA).

4. Diagnosis and evaluation

Confirm diagnosis with guideline-based history, exam, and indicated testing.
Screen for severity, complications, and high-risk comorbid conditions.
Identify social or access barriers that could affect treatment success.

5. Treatment (non-pharmacologic)

Nutrition, activity, sleep, stress, and behavior-change coaching.
Longitudinal goals emphasize health outcomes, not only scale weight.

6. Treatment (pharmacologic)

Common anti-obesity medications include semaglutide, tirzepatide, phentermine/topiramate ER, naltrexone/bupropion ER, liraglutide, and orlistat.
Agent selection should reflect efficacy needs, diabetes risk, blood pressure, psychiatric history, pregnancy potential, and coverage/access constraints.
Bariatric or metabolic surgery referral is appropriate for guideline-eligible patients when medication and lifestyle therapy are insufficient.

7. Monitoring and follow-up

Weight trend, waist/metabolic markers, adverse effects, adherence, and quality-of-life outcomes.

8. Practical counseling points

Give patients a clear “what to do today / when to call / when to seek urgent care” plan.
Use teach-back to confirm understanding of treatment goals and medication instructions.
Simplify regimens when possible to improve adherence and outcomes.

9. Red flags and escalation

Escalate care urgently for severe or rapidly worsening symptoms.
Reassess diagnosis if expected response does not occur within the anticipated timeline.

10. Guideline references

AACE/ACE obesity management guidance.
Obesity Medicine Association clinical recommendations.
ADA and cardiometabolic society guidance where relevant.

Note: Educational guide only; not a substitute for individualized medical care.